Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R De Groot

Showing results (441-450 of 467) with videos related to

Pageof 47
Sort By:
Cardiovascular Diabetology|December 26, 2025
Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuationEva R Meulendijks, Benedetta Fabrizi, Steffen Bruns, et al.
Breast Cancer Research and Treatment|September 27, 2008
Validation of 70-gene prognosis signature in node-negative breast cancerJ M Bueno-de-Mesquita, S C Linn, R Keijzer, et al.
Heart Rhythm|July 31, 2021
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trialNicoline W E van den Berg, Jolien Neefs, Makiri Kawasaki, et al.
Journal of Translational Medicine|June 6, 2023
Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillationEva R Meulendijks, Rushd F M Al-Shama, Makiri Kawasaki, et al.
Journal of Medical Genetics|September 26, 2007
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome)M M Hagleitner, A Lankester, P Maraschio, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 10, 2020
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE VRuben R De With, Ömer Erküner, Michiel Rienstra, et al.
Molecular Therapy. Methods & Clinical Development|August 8, 2025
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administrationJianan Wang, Timo Jonker, Aina Cervera-Barea, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 15, 2021
Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registryÖ Erküner, M van Eck, O Xhaet, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trialNina Becher, Gina Köllner, Emanuele Bertaglia, et al.
Pageof 47

Showing results (441-450 of 467) with videos related to

Sort By:
Pageof 47
Cardiovascular Diabetology|December 26, 2025
Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuationEva R Meulendijks, Benedetta Fabrizi, Steffen Bruns, et al.
Breast Cancer Research and Treatment|September 27, 2008
Validation of 70-gene prognosis signature in node-negative breast cancerJ M Bueno-de-Mesquita, S C Linn, R Keijzer, et al.
Heart Rhythm|July 31, 2021
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trialNicoline W E van den Berg, Jolien Neefs, Makiri Kawasaki, et al.
Journal of Translational Medicine|June 6, 2023
Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillationEva R Meulendijks, Rushd F M Al-Shama, Makiri Kawasaki, et al.
Journal of Medical Genetics|September 26, 2007
Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome)M M Hagleitner, A Lankester, P Maraschio, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 10, 2020
Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE VRuben R De With, Ömer Erküner, Michiel Rienstra, et al.
Molecular Therapy. Methods & Clinical Development|August 8, 2025
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administrationJianan Wang, Timo Jonker, Aina Cervera-Barea, et al.
American Heart Journal|May 22, 2012
Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapyLouise R A Olde Nordkamp, Reinoud E Knops, Gust H Bardy, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 15, 2021
Contemporary management of patients with atrial fibrillation in the Netherlands and Belgium: a report from the EORP-AF long-term general registryÖ Erküner, M van Eck, O Xhaet, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trialNina Becher, Gina Köllner, Emanuele Bertaglia, et al.
Pageof 47